APA

Infante M., Durán M., Acedo A., Pérez-Cabornero L., Sanz D. J., García-González M., Beristain E., Esteban-Cardeñosa E., de la Hoya M., Teulé A., Vega A., Tejada M., Lastra E., Miner C. & Velasco E. A. (20100304). BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin. : Clinical genetics.

Chicago

Infante M, Durán M, Acedo A, Pérez-Cabornero L, Sanz D J, García-González M, Beristain E, Esteban-Cardeñosa E, de la Hoya M, Teulé A, Vega A, Tejada M-I, Lastra E, Miner C and Velasco E A. 20100304. BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin. : Clinical genetics.

Harvard

Infante M., Durán M., Acedo A., Pérez-Cabornero L., Sanz D. J., García-González M., Beristain E., Esteban-Cardeñosa E., de la Hoya M., Teulé A., Vega A., Tejada M., Lastra E., Miner C. and Velasco E. A. (20100304). BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin. : Clinical genetics.

MLA

Infante M, Durán M, Acedo A, Pérez-Cabornero L, Sanz D J, García-González M, Beristain E, Esteban-Cardeñosa E, de la Hoya M, Teulé A, Vega A, Tejada M-I, Lastra E, Miner C and Velasco E A. BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin. : Clinical genetics. 20100304.